-
1
-
-
0035383762
-
Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects
-
McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001;97:3390-3400.
-
(2001)
Blood
, vol.97
, pp. 3390-3400
-
-
McSweeney, P.A.1
Niederwieser, D.2
Shizuru, J.A.3
-
2
-
-
0037441604
-
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases
-
Niederwieser D, Maris M, Shizuru JA, et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood. 2003;101:1620-1629.
-
(2003)
Blood
, vol.101
, pp. 1620-1629
-
-
Niederwieser, D.1
Maris, M.2
Shizuru, J.A.3
-
3
-
-
10744222061
-
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
-
Maris MB, Niederwieser D, Sandmaier BM, et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood. 2003;102:2021-2030.
-
(2003)
Blood
, vol.102
, pp. 2021-2030
-
-
Maris, M.B.1
Niederwieser, D.2
Sandmaier, B.M.3
-
4
-
-
0142152420
-
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
-
Maloney DG, Molina AJ, Sahebi F, et al. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood. 2003;102: 3447-3454.
-
(2003)
Blood
, vol.102
, pp. 3447-3454
-
-
Maloney, D.G.1
Molina, A.J.2
Sahebi, F.3
-
5
-
-
0032006125
-
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
-
Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91:756-763.
-
(1998)
Blood
, vol.91
, pp. 756-763
-
-
Slavin, S.1
Nagler, A.2
Naparstek, E.3
-
6
-
-
0030925301
-
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
-
Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 1997;89:4531-4536.
-
(1997)
Blood
, vol.89
, pp. 4531-4536
-
-
Giralt, S.1
Estey, E.2
Albitar, M.3
-
7
-
-
0031879197
-
Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
-
Khouri IF, Keating M, Körbling M, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998;16:2817-2824.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2817-2824
-
-
Khouri, I.F.1
Keating, M.2
Körbling, M.3
-
8
-
-
0033642531
-
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
-
Spitzer TR, McAfee S, Sackstein R, et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant. 2000;6:309-320.
-
(2000)
Biol Blood Marrow Transplant
, vol.6
, pp. 309-320
-
-
Spitzer, T.R.1
McAfee, S.2
Sackstein, R.3
-
9
-
-
0033230960
-
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
-
Childs R, Clave E, Contentin N, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood. 1999;94:3234-3241.
-
(1999)
Blood
, vol.94
, pp. 3234-3241
-
-
Childs, R.1
Clave, E.2
Contentin, N.3
-
10
-
-
0034307366
-
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
-
Kottaridis PD, Milligan DW, Chopra R, et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood. 2000;96:2419-2425.
-
(2000)
Blood
, vol.96
, pp. 2419-2425
-
-
Kottaridis, P.D.1
Milligan, D.W.2
Chopra, R.3
-
11
-
-
0034885941
-
Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients
-
Bornhauser M, Thiede C, Platzbecker U, et al. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clin Cancer Res. 2001;7: 2254-2262.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2254-2262
-
-
Bornhauser, M.1
Thiede, C.2
Platzbecker, U.3
-
12
-
-
0037623948
-
Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival
-
Keil F, Prinz E, Moser K, et al. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival. Transplantation. 2003;76:230-236.
-
(2003)
Transplantation
, vol.76
, pp. 230-236
-
-
Keil, F.1
Prinz, E.2
Moser, K.3
-
13
-
-
0042160845
-
Low dose TBI conditioning for hematopoietic stem cell transplants (HSCT) from HLA-matched related donors for patients with hematologic malignancies: Influence of fludarabine or cytoreductive autografts on outcome
-
Abstract no. 544
-
Sandmaier BM, Maloney DG, Gooley TA, et al. Low dose TBI conditioning for hematopoietic stem cell transplants (HSCT) from HLA-matched related donors for patients with hematologic malignancies: influence of fludarabine or cytoreductive autografts on outcome [abstract]. Blood. 2002;100(pt 1):145a. Abstract no. 544.
-
(2002)
Blood
, vol.100
, Issue.PART 1
-
-
Sandmaier, B.M.1
Maloney, D.G.2
Gooley, T.A.3
-
16
-
-
0036660429
-
Therapy for chronic graft-versus-host disease: A randomized trial comparing cyclosporine plus prednisone versus prednisone alone
-
Koc S, Leisenring W, Flowers MED, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood. 2002;100:48-51.
-
(2002)
Blood
, vol.100
, pp. 48-51
-
-
Koc, S.1
Leisenring, W.2
Flowers, M.E.D.3
-
17
-
-
0036400055
-
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study
-
Junghanss C, Marr KA, Carter RA, et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant. 2002;8:512-520.
-
(2002)
Biol Blood Marrow Transplant
, vol.8
, pp. 512-520
-
-
Junghanss, C.1
Marr, K.A.2
Carter, R.A.3
-
18
-
-
0042243672
-
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning
-
Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood. 2003;102:827-833.
-
(2003)
Blood
, vol.102
, pp. 827-833
-
-
Fukuda, T.1
Boeckh, M.2
Carter, R.A.3
-
19
-
-
0026509756
-
Tetranucleotide repeat polymorphism at the human beta-actin related pseudogene H-beta Acpsi-2 (ACTBP2)
-
Polymeropoulos MH, Rath DS, Xiao H, Merril CR. Tetranucleotide repeat polymorphism at the human beta-actin related pseudogene H-beta Acpsi-2 (ACTBP2). Nucleic Acids Res. 1992;20: 1432-1432.
-
(1992)
Nucleic Acids Res
, vol.20
, pp. 1432-1432
-
-
Polymeropoulos, M.H.1
Rath, D.S.2
Xiao, H.3
Merril, C.R.4
-
20
-
-
0026893558
-
A further tetranucleotide repeat polymorphism in the vWF gene
-
Kimpton C, Walton A, Gill P. A further tetranucleotide repeat polymorphism in the vWF gene. Hum Mol Genet. 1992;1:287.
-
(1992)
Hum Mol Genet
, vol.1
, pp. 287
-
-
Kimpton, C.1
Walton, A.2
Gill, P.3
-
21
-
-
3042871056
-
Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3′ hypervariable region
-
Boerwinkle E, Xiong WJ, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci U S A. 1989;86:212-216.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 212-216
-
-
Boerwinkle, E.1
Xiong, W.J.2
Fourest, E.3
Chan, L.4
-
22
-
-
0025034355
-
Amplification of a variable number of tandem repeats (VNTR) locus (pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science
-
Kasai K, Nakamura Y, White R. Amplification of a variable number of tandem repeats (VNTR) locus (pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science. J Forensic Sci. 1990;35:1196-1200.
-
(1990)
J Forensic Sci
, vol.35
, pp. 1196-1200
-
-
Kasai, K.1
Nakamura, Y.2
White, R.3
-
23
-
-
0026787565
-
Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay
-
Reichert WL, Stein JE, French B, Goodwin P, Varanasi U. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay. Carcinogenesis. 1992;13:1475-1479.
-
(1992)
Carcinogenesis
, vol.13
, pp. 1475-1479
-
-
Reichert, W.L.1
Stein, J.E.2
French, B.3
Goodwin, P.4
Varanasi, U.5
-
24
-
-
0001769478
-
Mixed chimerism after transplantation of allogeneic hematopoietic cells
-
Thomas ED, Blume KG, Forman SJ, eds. Boston, MA: Blackwell Science
-
Storb R, Yu C, McSweeney P. Mixed chimerism after transplantation of allogeneic hematopoietic cells. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. 2nd ed. Boston, MA: Blackwell Science; 1999:287-295.
-
(1999)
Hematopoietic Cell Transplantation. 2nd Ed.
, pp. 287-295
-
-
Storb, R.1
Yu, C.2
McSweeney, P.3
-
25
-
-
0034769445
-
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings
-
Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings (Review). Biol Blood Marrow Transplant. 2001;7:473-485.
-
(2001)
Biol Blood Marrow Transplant
, vol.7
, pp. 473-485
-
-
Antin, J.H.1
Childs, R.2
Filipovich, A.H.3
-
26
-
-
0032878340
-
Construction and optimization of a dog whole-genome radiation hybrid panel
-
Vignaux F, Hitte C, Priat C, Chuat JC, Andre C, Galibert F. Construction and optimization of a dog whole-genome radiation hybrid panel. Mamm Genome. 1999;10:888-894.
-
(1999)
Mamm Genome
, vol.10
, pp. 888-894
-
-
Vignaux, F.1
Hitte, C.2
Priat, C.3
Chuat, J.C.4
Andre, C.5
Galibert, F.6
-
27
-
-
9144246514
-
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation
-
Baron F, Schaaf-Lafontaine N, Humblet-Baron S, et al. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation. 2003;76:1705-1713.
-
(2003)
Transplantation
, vol.76
, pp. 1705-1713
-
-
Baron, F.1
Schaaf-Lafontaine, N.2
Humblet-Baron, S.3
-
28
-
-
10744219960
-
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning
-
Maris M, Boeckh M, Storer B, et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Exp Hematol. 2003;31:941-952.
-
(2003)
Exp Hematol
, vol.31
, pp. 941-952
-
-
Maris, M.1
Boeckh, M.2
Storer, B.3
-
29
-
-
0037085790
-
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study
-
Junghanss C, Boeckh M, Carter RA, et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood. 2002;99:1978-1985.
-
(2002)
Blood
, vol.99
, pp. 1978-1985
-
-
Junghanss, C.1
Boeckh, M.2
Carter, R.A.3
-
30
-
-
0037354356
-
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning
-
Valcarcel D, Martino R, Caballero D, et al. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant. 2003;31:387-392.
-
(2003)
Bone Marrow Transplant
, vol.31
, pp. 387-392
-
-
Valcarcel, D.1
Martino, R.2
Caballero, D.3
-
31
-
-
0842328807
-
+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in solid tumor patients
-
Prepublished on October 9, as DOI 10.1182/blood-2003-04-1170
-
+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in solid tumor patients. Blood. Prepublished on October 9, 2003, as DOI 10.1182/blood-2003-04-1170. (Now available as Blood. 2004;103: 1560-1563).
-
(2003)
Blood
-
-
Carvallo, C.1
Geller, N.2
Kurlander, R.3
-
32
-
-
0842328807
-
-
+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in solid tumor patients. Blood. Prepublished on October 9, 2003, as DOI 10.1182/blood-2003-04-1170. (Now available as Blood. 2004;103: 1560-1563).
-
(2004)
Blood
, vol.103
, pp. 1560-1563
-
-
-
33
-
-
0035203549
-
G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in non-myeloablated canine recipients: CD3 cells are required
-
Zaucha JM, Zellmer E, Georges G, et al. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in non-myeloablated canine recipients: CD3 cells are required. Biol Blood Marrow Transplant. 2001;7: 613-619.
-
(2001)
Biol Blood Marrow Transplant
, vol.7
, pp. 613-619
-
-
Zaucha, J.M.1
Zellmer, E.2
Georges, G.3
-
34
-
-
0022602179
-
Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease
-
Hill RS, Petersen FB, Storb R, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood. 1986;67:811-816.
-
(1986)
Blood
, vol.67
, pp. 811-816
-
-
Hill, R.S.1
Petersen, F.B.2
Storb, R.3
-
35
-
-
0142182271
-
Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: Potential predictive value of NK cell chimaerism for late graft rejection
-
Matthes-Martin S, Lion T, Haas OA, et al. Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection. Leukemia. 2003;17:1934-1942.
-
(2003)
Leukemia
, vol.17
, pp. 1934-1942
-
-
Matthes-Martin, S.1
Lion, T.2
Haas, O.A.3
-
36
-
-
0023552675
-
Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies
-
Petz LD, Yam P, Wallace RB, et al. Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood. 1987;70:1331-1337.
-
(1987)
Blood
, vol.70
, pp. 1331-1337
-
-
Petz, L.D.1
Yam, P.2
Wallace, R.B.3
-
37
-
-
85009893939
-
Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation
-
Schaap N, Schattenberg A, Mensink E, et al. Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation. Leukemia. 2002;16:13-21.
-
(2002)
Leukemia
, vol.16
, pp. 13-21
-
-
Schaap, N.1
Schattenberg, A.2
Mensink, E.3
-
38
-
-
0028206129
-
Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
-
Mackinnon S, Barnett L, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood. 1994;83:3409-3416.
-
(1994)
Blood
, vol.83
, pp. 3409-3416
-
-
Mackinnon, S.1
Barnett, L.2
Heller, G.3
O'Reilly, R.J.4
-
39
-
-
10244244934
-
Effect of mixed chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia
-
Huss R, Deeg HJ, Gooley T, et al. Effect of mixed chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplant. 1996;18:767-776.
-
(1996)
Bone Marrow Transplant
, vol.18
, pp. 767-776
-
-
Huss, R.1
Deeg, H.J.2
Gooley, T.3
|